ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $49,261 | -11.5% | 44,783 | -0.3% | 0.00% | – |
| Q1 2024 | $55,678 | -60.8% | 44,902 | -66.8% | 0.00% | -100.0% |
| Q4 2023 | $142,060 | -51.8% | 135,295 | +214.5% | 0.00% | -50.0% |
| Q3 2023 | $294,714 | -51.8% | 43,024 | -27.0% | 0.00% | -50.0% |
| Q2 2023 | $611,011 | +37.4% | 58,921 | +7.2% | 0.00% | +33.3% |
| Q1 2023 | $444,748 | +247.5% | 54,975 | +578.0% | 0.00% | +200.0% |
| Q3 2022 | $128,000 | +1.6% | 8,109 | -10.4% | 0.00% | 0.0% |
| Q2 2022 | $126,000 | +113.6% | 9,050 | +163.9% | 0.00% | – |
| Q1 2022 | $59,000 | -80.7% | 3,429 | -83.7% | 0.00% | -100.0% |
| Q4 2021 | $306,000 | -10.5% | 21,012 | +10.6% | 0.00% | -25.0% |
| Q3 2021 | $342,000 | -63.4% | 19,000 | -64.3% | 0.00% | -63.6% |
| Q2 2021 | $935,000 | -42.2% | 53,257 | -17.0% | 0.01% | -47.6% |
| Q1 2021 | $1,618,000 | +14609.1% | 64,202 | +509.5% | 0.02% | – |
| Q3 2019 | $11,000 | -54.2% | 10,533 | -4.5% | 0.00% | – |
| Q2 2019 | $24,000 | -81.1% | 11,033 | -47.8% | 0.00% | -100.0% |
| Q1 2019 | $127,000 | -80.0% | 21,148 | -75.4% | 0.00% | -86.7% |
| Q4 2018 | $636,000 | +335.6% | 86,062 | +929.3% | 0.03% | +233.3% |
| Q1 2018 | $146,000 | +342.4% | 8,361 | +518.4% | 0.01% | +350.0% |
| Q4 2017 | $33,000 | -76.8% | 1,352 | -75.5% | 0.00% | -75.0% |
| Q3 2017 | $142,000 | – | 5,517 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,808,034 | $29,119,313 | 14.32% |
| Foresite Capital Management V, LLC | 1,258,243 | $13,047,980 | 9.53% |
| GREAT POINT PARTNERS LLC | 1,941,581 | $20,134,195 | 3.94% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $35,258,000 | 3.63% |
| Aisling Capital Management LP | 434,455 | $4,505,298 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 651,400 | $6,755,018 | 2.09% |
| VR Adviser, LLC | 1,040,754 | $10,792,619 | 1.73% |
| Ikarian Capital, LLC | 796,300 | $8,257,631 | 1.32% |
| Samsara BioCapital, LLC | 696,171 | $7,219,293 | 1.27% |
| BRAIDWELL LP | 2,901,194 | $30,085,382 | 0.98% |